Breaking News, Financial News

Financial Report: WuXi PharmaTech

Lab services up 13% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech 1Q Revenues: $131.9 Million (+12%) 1Q Earnings: $21.7 million (+3%) Comments: Laboratory services grew 13% to $97.5 million in the quarter with China-based lab services up 16% to $74.5 million, and U.S. services up 4% to $23.0 million. Manufacturing services revenue grew 10% to $34.4 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters